ReforteHA treatment is considered a bioremodelling therapy. This unique stabilized hybrid cooperative HA complex has different biological properties when compared to monotherapy with either High or Low molecular weight HAs. The resistance to enzymatic degradation, slow release action and biocompatibility properties makes it different from the standard HAs in today's market